FDA NDC Directory · JSON-LD · Markdown

EVOTAZ

NDC 0003-3641 · HUMAN PRESCRIPTION DRUG · TABLET

Generic nameatazanavir and cobicistat
Labeler / ManufacturerE.R. Squibb & Sons, L.L.C.
Marketing categoryNew Drug Application (innovator) · App NDA206353
Dosage form / routeTABLET · ORAL
Active ingredientsATAZANAVIR SULFATE (300 mg/1)
COBICISTAT (150 mg/1)
Marketing started20150129
Package count1

External sources

Source: openFDA. Public-domain (CC0).